See how a robotic-assisted innovation could help with knee-replacement surgery

Over three million people have knee-replacement surgery each year. The VELYS^TM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.

October 11, 2021

More from Johnson & Johnson

Innovation

June 1, 2026

Striving for a cure for multiple myeloma: What HCPs need to know

Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

Innovation

May 20, 2026

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

Health & wellness

May 19, 2026

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.

Search Results

No Results

See how a robotic-assisted innovation could help with knee-replacement surgery

Over three million people have knee-replacement surgery each year. The VELYSTM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.

More from Johnson & Johnson

Striving for a cure for multiple myeloma: What HCPs need to know

The future of immunology

What is inflammation?

Over three million people have knee-replacement surgery each year. The VELYS^TM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.